Chemical and structural biology of nucleic acids and protein-nucleic acid complexes for novel drug discovery

被引:9
作者
Gan JianHua [1 ]
Sheng Jia [1 ]
Huang Zhen [1 ]
机构
[1] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA
基金
美国国家科学基金会;
关键词
nucleic acid targets; DNA and RNA; protein-nucleic acid complexes; DNA duplex and junction; G-quadruplex; ribozyme; riboswitch; ribosome; topoisomerase; inhibitors; antibiotics; structure-based drug design; therapeutic agents; BACTERIAL GENE-EXPRESSION; MESSENGER-RNA STRUCTURE; LARGE RIBOSOMAL-SUBUNIT; DNA HOLLIDAY JUNCTION; NOVA G-QUADRUPLEX; CLEAVE IN-VITRO; CRYSTAL-STRUCTURE; C-MYC; HAMMERHEAD RIBOZYME; MOLECULAR-RECOGNITION;
D O I
10.1007/s11426-010-4174-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Since nucleic acids (DNA and RNA) play very important roles in cells, they are molecular targets of many clinically used drugs, such as anticancer drugs and antibiotics. Because of clinical demands for treating various deadly cancers and drug-resistant strains of pathogens, there are urgent needs to develop novel therapeutic agents. Targeting nucleic acids hasn't been the mainstream of drug discovery in the past, and the lack of 3D structural information for designing and developing drug specificity is one of the main reasons. Fortunately, many important structures of nucleic acids and their protein complexes have been determined over the past decade, which provide novel platforms for future drug design and discovery. In this review, we describe some useful nucleic acid structures, particularly their interactions with the ligands and therapeutic candidates or even drugs. We summarize important information for designing novel potent drugs and for targeting nucleic acids and protein-nucleic acid complexes to treat cancers and overcome the drug-resistant problems.
引用
收藏
页码:3 / 23
页数:21
相关论文
共 181 条
[1]   In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis [J].
Abounader, R ;
Lal, B ;
Luddy, C ;
Koe, G ;
Davidson, B ;
Rosen, EM ;
Laterra, J .
FASEB JOURNAL, 2001, 15 (13) :108-+
[2]   Crystal structure of a self-splicing group I intron with both exons [J].
Adams, PL ;
Stahley, MR ;
Kosek, AB ;
Wang, JM ;
Strobel, SA .
NATURE, 2004, 430 (6995) :45-50
[3]  
Akkina R, 2003, ANTICANCER RES, V23, P1997
[4]   Ribosomal antibiotics: structural basis for resistance, synergism and selectivity [J].
Auerbach, T ;
Bashan, A ;
Yonath, A .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (11) :570-576
[5]   RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model [J].
Bai, JR ;
Banda, N ;
Lee, NS ;
Rossi, J ;
Akkina, R .
MOLECULAR THERAPY, 2002, 6 (06) :770-782
[6]   Oxazolidinone structure-activity relationships leading to linezolid [J].
Barbachyn, MR ;
Ford, CW .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (18) :2010-2023
[7]   Type IIA topoisomerase inhibition by a new class of antibacterial agents [J].
Bax, Benjamin D. ;
Chan, Pan F. ;
Eggleston, Drake S. ;
Fosberry, Andrew ;
Gentry, Daniel R. ;
Gorrec, Fabrice ;
Giordano, Ilaria ;
Hann, Michael M. ;
Hennessy, Alan ;
Hibbs, Martin ;
Huang, Jianzhong ;
Jones, Emma ;
Jones, Jo ;
Brown, Kristin Koretke ;
Lewis, Ceri J. ;
May, Earl W. ;
Saunders, Martin R. ;
Singh, Onkar ;
Spitzfaden, Claus E. ;
Shen, Carol ;
Shillings, Anthony ;
Theobald, Andrew J. ;
Wohlkonig, Alexandre ;
Pearson, Neil D. ;
Gwynn, Michael N. .
NATURE, 2010, 466 (7309) :935-U51
[8]  
BEREZOVSKII VM, 1977, BIOORG KHIM+, V3, P521
[9]  
BERGERAT A, 1994, J BIOL CHEM, V269, P27663
[10]   An atypical topoisomerase II from archaea with implications for meiotic recombination [J].
Bergerat, A ;
deMassy, B ;
Gadelle, D ;
Varoutas, PC ;
Nicolas, A ;
Forterre, P .
NATURE, 1997, 386 (6623) :414-417